Related Experiment Video
Updated: Aug 6, 2026

All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System
Published on: December 20, 2021
Gomisin G Inhibits Pancreatic Cancer Cell Growth by Promoting YAP Degradation
Lan Li1, Jiayu Chen2, Jiayi Shao2
1School of Public Health Wenzhou Medical University Wenzhou China.
Abstract:
Pancreatic cancer is highly lethal, with a five-year survival rate of less than 5%. Gomisin G, extracted from the fruit of Schisandra chinensis, is known for its anti-tumor, anti-inflammatory, and antioxidant properties. However, its specific effects on pancreatic cancer and the underlying mechanisms remain unclear. In this study, we used a colony formation assay to evaluate the impact of Gomisin G on pancreatic cancer cell proliferation and colony formation. Flow cytometry and western blot analyses revealed that Gomisin G induces G1 phase arrest by modulating the expression of cyclin D1, p21, p27, and Rb activity, and triggers apoptosis in pancreatic cancer cells. Using a mouse xenograft model, we found that Gomisin G significantly inhibits the growth of PANC-1 pancreatic tumors. Mechanistically, RNA-seq, western blot, qPCR, and confocal microscopy showed that Gomisin G promotes LATS1-mediated YAP phosphorylation, accelerates YAP protein degradation, reduces its nuclear localization, and down-regulates the mRNA levels of the target genes CTGF and CYR61 in the Hippo-YAP pathway. Overall, our findings suggest that Gomisin G has significant anti-cancer activity against pancreatic cancer and may be a promising candidate for therapeutic development.
Insights
Gomisin G, derived from Schisandra chinensis, effectively inhibits pancreatic cancer growth and proliferation. It works by inducing cell cycle arrest and apoptosis, and by targeting the Hippo-YAP pathway, offering a promising therapeutic avenue.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Pancreatic cancer has a very low survival rate.
- Gomisin G exhibits known anti-tumor properties.
- Mechanisms of Gomisin G in pancreatic cancer are not well understood.
Purpose of the Study:
- To investigate the anti-cancer effects of Gomisin G on pancreatic cancer.
- To elucidate the underlying molecular mechanisms of Gomisin G action.
Main Methods:
- Colony formation assay, flow cytometry, and western blot analysis.
- Mouse xenograft model (PANC-1 tumors).
- RNA-seq, qPCR, and confocal microscopy to analyze the Hippo-YAP pathway.
Main Results:
- Gomisin G inhibited pancreatic cancer cell proliferation and colony formation.
- It induced G1 phase arrest and apoptosis by modulating cell cycle regulators.
- Gomisin G suppressed PANC-1 tumor growth in vivo.
- It inhibited the Hippo-YAP pathway by promoting LATS1-mediated YAP phosphorylation and degradation.
Conclusions:
- Gomisin G demonstrates significant anti-cancer activity against pancreatic cancer.
- It acts through cell cycle arrest, apoptosis induction, and Hippo-YAP pathway inhibition.
- Gomisin G is a potential therapeutic candidate for pancreatic cancer treatment.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Inhibition of Cdk Activity
Abnormal Proliferation
Negative Regulator Molecules
